Distinct in vitro Complement Activation by Various Intravenous Iron Preparations
Conclusion: This study provides evidence that iron dextran and ferric carboxymaltose have complement-activating capacities in-vitro, and hypersensitivity reactions to these drugs could be CARPA-mediated.Am J Nephrol 2017;45:49-59
Source: American Journal of Nephrology - Category: Neurology Source Type: research
More News: Allergy | Allergy & Immunology | Anaphylactic Shock | Anemia | Dialysis | Hemodialysis | Neurology | Study | Urology & Nephrology